Your session is about to expire
← Back to Search
Donor Stem Cell Infusion for Kidney Transplant
Study Summary
This trial is testing a new way to give kidney transplants that may allow patients to reduce or stop taking immunosuppressive drugs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I currently have an active infection.I can stay within a four-hour drive of the trial site for the first three months.The match between the donor and recipient is not compatible.I am getting my first kidney transplant.The test between the donor and recipient shows that they are not a good match.I am not pregnant and agree to use birth control for a year after my transplant.There are signs that your immune system remembers and reacts to the organ or tissue donor.My BMI is either above 35 or below 18.You have signs of a viral infection that would make it unsafe for you to get a kidney transplant.I am receiving a kidney transplant only.I've had radiation therapy at a dose too high for total body irradiation.I am between 18 and 65 years old and qualify for a kidney transplant due to organ failure.My insurance or funding will cover my transplant and any research-related issues.
- Group 1: Living or Deceased Donor Kidney Allograft
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are recruitment efforts underway for this investigation?
"According to the information hosted on clinicaltrials.gov, this particular medical study is not currently enlisting new patients for participation. This trial was first published in January of 2005 and last edited in July 2022; however, there are 177 alternate trials presently seeking candidates."
What criteria must be met to qualify for participation in this experiment?
"This medical investigation is searching for 38 volunteers with end-organ kidney failure aged between 18 and 65. Eligibility requirements include the ability to stay within a four hour radius of the clinical site during the first three months after transplant, having negative crossmatching results in terms of donor-recipient compatibility, proof of coverage that can fund any research complications or associated costs, as well as a confirmed absence of pregnancy 48 hours before total body irradiation commences; furthermore, women who are capable of reproduction must also be willing to use reliable contraception for one year post-transplantation."
Does this research protocol include individuals below the age of 35?
"According to the study's enrollment criteria, only individuals between 18 and 65 years old can be considered eligible participants."
Share this study with friends
Copy Link
Messenger